Skip to main content

View full-text article in PMC

. 2014 Jun 20;5(14):5246–5256. doi: 10.18632/oncotarget.2124

Table 3. Patients’ characteristics according to levels of sHGF.

Patients’ characteristics		sHGF low^* N (%)	sHGF high^** N (%)	p-value
Age	Mean (SD)	65.3 (10.4)	66.6 (10.8)	0.52
Gender	Male	39 (75)	43 (82.7)	0.34
Gender	Female	13 (25)	9 (17.3)	0.34
Tobacco history	Current	41 (78.8)	37 (71.2)	0.36
Tobacco history	Former	11 (21.2)	15 (28.8)	0.36
PS	0-1	43 (82.7)	28 (53.8)	0.002
PS	2-4	9 (17.3)	24 (46.2)	0.002
Treatment	Yes	49 (94.2)	45 (88.2)	0.32
Treatment	No	3 (5.8)	6 (11.8)	0.32
Stage	I-III	17 (32.7)	11 (21.2)	0.18
Stage	IV	35 (67.3)	41 (78.8)	0.18

sHGF: serum Hepatocyte Growth Factor; SD: standard deviation; N: number

^*

sHGF levels <=1886.10 pg/ml;

^**

sHGF levels >1886.10 pg/ml